Author

Charles Walworth

Institution: LabCorp (United States)

Observed institution: LabCorp (United States)

OpenAlex ID: A5138003840

Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network

2026 · Richard Elion, Cassidy Henegar, et al. · HIV Medicine

Persistence and virologic outcomes of people with HIV (PWH) with suboptimal adherence on B/F/TAF or dolutegravir-based single-tablet regimens

2026 · Graeme Moyle, Joshua Gruber, et al. · Figshare

Persistence and virologic outcomes of people with HIV (PWH) with suboptimal adherence on B/F/TAF or dolutegravir-based single-tablet regimens

2026 · Graeme Moyle, Joshua Gruber, et al. · Future Virology

People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes

2026 · Paul E. Sax, Keith J. Dunn, et al. · AIDS Patient Care and STDs

Works count: 4

Citation count:

H-index:

I10-index: